Undetermined: Prior to chemotherapy for lymphoma the survival was dismal. With the introduction of CHOPP survival went to 50%. With the introduction of Rituxan (rituximab) targeting CD20 in the lymphocyte the survival reached 90% and now newer drugs targeting the lymphocytes are in clinical trials.
Answered 10/19/2014
3.6k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question